Objectives This study sought to investigate the frequency, predictors, and detailed qualitative and quantitative assessment of optical coherence tomography (OCT)-detected stent edge dissections. Its impact on subsequent management and clinical outcomes were also investigated.
Plaque fracture and dissection of the arterial wall are key mechanisms of lumen enlargement after balloon angioplasty (1, 2) . During stent implantation, unplanned vessel tearing may occur at the transition between the rigid stent struts and the adjacent arterial wall (3) , which has been associated with increased risks of thrombosis and major adverse cardiac events (MACE) (4) (5) (6) (7) (8) .
Coronary angiography (9) and intravascular ultrasound (IVUS) (3, 10) have traditionally been used for the diagnosis of dissections at stent edges. Reported incidences of stent edge dissection range from 5% to 23% of the percutaneous coronary intervention (PCI) procedures as detected by IVUS (3) . The superior resolution (12 to 18 mm) (11) of lightbased optical coherence tomography (OCT) compared with IVUS (150 to 250 mm) may lead to more frequent recognition of vascular injury during PCI (12, 13) . Although physicians welcome better imaging and more knowledge of the vascular response to PCI, they face a clinical dilemma on the subsequent management of OCT findings. Recent reports provided early insights on the incidence and characteristics of stent edge dissections by OCT (14, 15) , but the inherent selection bias of retrospective, small studies have limited our understanding of the true incidence and clinical implications of OCT-detected stent edge dissections. Therefore, the goals of the present study were to: 1) determine the frequency of stent edge dissections by OCT in a large, unrestricted population representative of the daily clinical practice; 2) perform a detailed morphometric assessment of stent edge dissections and identify potential factors associated with its occurrence; 3) assess the impact of the OCT findings on the clinical management of edge dissections in real practice; and 4) examine the clinical outcomes of OCT-detected edge dissections.
Methods
Study population, study design, and PCI procedures. OCT was adopted as the standard intravascular imaging modality at our Institution after its approval by the U.S. Food and Drug Administration in May 2010. The University Hospitals Case Medical Center OCT Program is a prospective initiative approved by the local institutional review board, and comprises 2 distinct phases: Phase I (September to October 2010) was a quality initiative program designed to evaluate safety, feasibility, and clinical impact of OCT usage on patient management in the daily practice. During this phase, OCT was performed in all patients undergoing a coronary intervention or requiring an invasive evaluation of intermediate coronary lesions (16) . There were no pre-defined exclusion criteria, thus representing an "all-comers," unrestricted use of OCT; Phase II, from November 2010 onward, comprised the "real-world" clinical utilization of OCT per the operator's discretion, thus representing a "selective use" of OCT in routine practice. All patients submitted to OCT examination from September 2010 to June 2011 were prospectively entered into a dedicated database, and comprise the population included in the current analysis.
PCI was performed per standard practice. Patients were treated with a loading dose of aspirin 300 mg and clopidogrel 300 mg or 600 mg. At the beginning of the procedure, a weight-adjusted (100 IU/kg) bolus of unfractionated heparin or a bolus of bivalirudin (0.75 mg/kg) was administered. Additional heparin boluses or continuous intravenous infusion of bivalirudin 1.75 mg/kg/h were given in order to maintain an activated clotting time !250 s. Glycoprotein IIb/IIIa inhibitors were used as per the operator's discretion. OCT imaging was mandatory in Phase I and left at the operator's discretion during Phase II. No formal recommendations were given regarding the management of stent edge dissection identified by OCT, which allowed proper assessment of the operator reaction to OCT findings without bias. Angiographic analysis. All angiograms were analyzed off-line for the presence of stent edge dissections by 2 experienced interventional cardiologists blinded to the OCT findings. The target lesion was classified according to the American College of Cardiology/American Heart Association classification system (17) . Severe calcification was characterized by the presence of radiopacities noted without cardiac motion before contrast injection, and generally compromising both sides of the arterial lumen (18) . Severe angulation was defined as an artery bend >60 (17) . Haziness was characterized as the presence of nonhomogeneous reduced contrast density within the arterial lumen, not fulfilling the criteria of definite thrombus or dissection (19, 20) . The step-up/ step-down phenomenon was characterized by an abrupt transition of the vessel caliber between the proximal and distal stent borders to its respective references (21) . Severity of stent edge dissections was classified according to the National Heart, Lung, and Blood Institute criteria as types A through F (9). Final coronary epicardial flow was classified according to the Thrombolysis In Myocardial Infarction criteria from 0 to 3 (22) . OCT image acquisition and analysis. OCT images were acquired with a commercially available Fourier-Domain OCT system (C7 XR OCT Intravascular Imaging System, St. Jude Medical, St. Paul, Minnesota) after intracoronary administration of 100 to 200 mg of nitroglycerin (unless clinically contraindicated) through conventional 6-F or 7-F guiding catheters. A 0.014-inch angioplasty guidewire was positioned distally in the target vessel, and the OCT catheter (C7 Dragonfly, St. Jude Medical) was advanced at least 10 mm distal to the distal stent edge. The entire length of the stented region was scanned using an integrated automated motorized pullback device at a speed of 20 mm/s. Continuous flush of iodine contrast medium (8 to 20 ml), through a power injector (3 to 7 ml/s at 300 psi), was performed to create a virtually blood-free environment and to trigger image acquisition. In cases with stented segments longer than 54 mm (the maximum scan length of the current OCT system), performance of another pullback was recommended to ensure visualization of the proximal stent edge. All OCT images were digitally stored and submitted to the institution's cardiovascular imaging core laboratory for off-line independent analysis.
All OCT runs were carefully screened for quality, and stent edges with <5 mm length or those with poor visualization due to artifacts or inadequate blood clearance were Chamié et al.
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Stent borders were defined as the first and last cross sections of the stented segment where struts could be seen in all 4 quadrants of the image. The peristent region consisted of the first frame immediately following the stent border (0.2 mm apart). Stent edges were defined as the 5-mm regions immediately adjacent to the stent borders, both distally and proximally. Edge dissection was defined as disruptions of the arterial lumen surface in the stent edge segment seen in at least 2 consecutive cross-section images. Its longitudinal length was calculated by multiplying the number of consecutive cross sections containing dissection by the slice thickness (pullback speed [mm/s] Â frame rate [s]).
Dissections were morphologically classified as flaps and cavities. Specific morphometric parameters for each flap (Fig. 1A) and cavity (Fig. 1B) were calculated to estimate the magnitude of dissections.
The severity of each dissection was further estimated according to a qualitative assessment of the depth of vessel injury as: 1) intimal (limited to the intima layer or atheroma); 2) medial (extending into the media layer); and 3) adventitial (extending through the external elastic membrane) (23) (Fig. 1C) . Presence of intramural hematoma was defined as an accumulation of flushing medium (or blood) within the Circumferential calcium distribution (degrees of arc) was measured using a protractor centered on the lumen (red solid arrows). Calcium-to-lumen distance (white solid lines) was determined as the distance between the luminal edge of the calcium and the lumen contour at a 15 interval (red dotted lines), and the average value was taken; right: fibrous cap (FC) quantification in lipid-rich plaques. The luminal boundary of the FC coincides with the lumen contour, and the abluminal boundary was automatically identified by a dynamic program algorithm that discriminates the optimal pixel intensity transition between the FC and lipid/necrotic core. The minimal distance from every locus in the luminal boundary of the FC to its abluminal boundary was automatically computed, and the minimum and mean FC thicknesses were recorded. FC surface area was determined as the product of the frame interval, and the arc length of the FC summed over involved frames (26) . The red and green arrows indicate the minimum and maximum FC thicknesses, respectively. medial space, displacing the internal elastic membrane inward and the external elastic membrane outward (23) . The intramural hematoma area was determined by planimetry, and its longitudinal length calculated (Fig. 1D) . Intraluminal thrombus was characterized as a mass attached to the luminal surface or floating within the lumen (23) (Fig. 1D) . Presence of atherosclerotic disease at the stent edges was investigated (Fig. 2) . A "normal" vessel was characterized by the presence of a 3-layered architecture comprising the evidence of intimal, medial, and adventitial layers (23) with an intimal thickness <250 mm (24) . Whenever atherosclerotic disease was present, plaques were classified according to previously described criteria as fibrotic, fibrocalcific, or lipidrich (23, 25) (Fig. 2B ). Circumferential distribution of calcium and calcium-to-lumen distance were determined for all calcified plaques (Fig. 2C) . In lipid-rich plaques, the entire extension of the overlying fibrous cap (FC) was semiautomatically segmented using a custom-built software, and the FC surface area and its minimum and mean thicknesses were automatically calculated (26) (Fig. 2C) . Thin-cap fibroatheroma (TCFA) was defined as a lipid-rich plaque with minimum FC thickness 65 mm (27) .
At the stent border, the stent area was measured, and the stent eccentricity index was calculated as: (maximum stent diameter À minimum stent diameter)/maximum stent diameter. Lumen eccentricity index was determined as (maximum lumen diameter À minimum lumen diameter)/ maximum lumen diameter. Lumen area stenosis was calculated as: ([mean lumen area À minimum lumen area]/mean lumen area Â 100). Stent diameter/lumen diameter ratio Flowchart showing inclusion and exclusion of subjects in each study phase. Incidence of OCT-detected dissection is presented for the total population and for each study phase. NIH ¼ neointimal hyperplasia; OCT ¼ optical coherence tomography; PCI ¼ percutaneous coronary intervention; UH-CMC ¼ University Hospitals Case Medical Center.
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A U G U S T 2 0 1 3 : 8 0 0 -1 3 and stent area/lumen area ratio were calculated at the peristent region and the 5-mm edges to investigate the degree of vessel stretching by the stent. Patient follow-up and clinical outcomes. Patients were followed up by telephone or hospital visit at 1, 6, and 12 months. MACE was recorded in a cumulative and hierarchical fashion, comprising the composite of death, nonfatal myocardial infarction (MI), and target lesion revascularization. Unless otherwise documented, all deaths were considered of cardiac origin. Occurrence of MI was defined according to the Joint ESC/ACCF/AHA/WHF Task Force for Redefinition of Myocardial Infarction (28) . Target lesion revascularization was defined as any revascularization procedure (either PCI or coronary artery bypass graft) of the target lesion in the presence of angiographic restenosis and signs and symptoms of ischemia. Target vessel revascularization was defined as any repeat revascularization (either PCI or coronary artery bypass graft) of the target vessel, including upstream and downstream branches and the target lesion itself. Stent thromboses were classified according to the Academic Research Consortium criteria (29) . Statistical analysis. All statistical analyses were performed using SAS software version 9.2 (SAS Institute, Cary, North Carolina), and statistical significance was assessed at the 0.05 level. Continuous variables are expressed as mean AE SD, and categorical variables are expressed as counts and percentages. For per-patient analyses, differences between the 2 groups were evaluated by the unpaired Student t test for continuous variables, and Fisher exact test for categorical variables. To estimate the differences between the 2 groups at the lesion or segment level, multilevel mixed models (which can address random effects at lesion, vessel, and subject levels) were used for binary and continuous outcomes comparison. Multivariate logistic regression models considering hierarchical data structure were developed, and odds ratios (ORs) were used to evaluate factors associated with dissection identification after adjusting significant univariate predictors.
Results
Incidence of OCT-detected stent edge dissection. Overall, 321 patients (345 lesions in 339 vessels) underwent intracoronary OCT investigation between September 2010 and June 2011, and during this period, OCT was performed after stenting in 266 patients (290 lesions in 276 vessels). After excluding cases in which OCT analysis could not be performed in part or in all of the pre-defined 5-mm edge segments, there were available for the final analysis a total of 395 stent edges (from 249 lesions in 236 vessels of 230 patients). A flowchart with the reasons for exclusion and the number of cases included in each phase of the study is presented in Figure 3 . Overall, the incidence of OCTdetected stent edge dissection was 39 Baseline clinical, angiographic, and procedural characteristics.
Baseline clinical characteristics are presented in Table 1 . The population with stent edge dissection was older, had higher rates of hypertension, and had a lower incidence of smokers in comparison to the group without dissection. Acute coronary syndromes were responsible for 68.7% of all PCI indications. Baseline angiographic characteristics are presented in Table 2 . The left anterior descending artery was the most frequently treated vessel in both groups. In comparison to the group without dissection, patients with edge dissection had more complex (American College of Cardiology/ American Heart Association type B2/C) lesions (79.8% vs. Chamié et al. (Fig. 4) . OCT qualitative assessment of stent edges. Qualitative assessment of stent edges by OCT is presented in Table 3 Table 1 ). OCT quantitative assessment of stent edges. Quantitative OCT assessment is also presented in Table 3 . Despite higher stent eccentricity in edges with dissection (0.11 AE 0.08 vs. 0.08 AE 0.05, p < 0.001), similar stent areas were observed in both dissected and nondissected edges. Mean lumen area and minimal lumen area were significantly smaller in dissected edges, with higher lumen eccentricity in comparison to nondissected edges. After PCI, percent diameter stenosis and percent area stenosis were also significantly higher in dissected edges.
Dissected edges had significantly higher stent/artery ratios. Interestingly, in comparison to distal dissected edges, proximal dissected edges presented significantly smaller stent diameter/lumen diameter (1.04 AE 0.13 vs. 1.13 AE 0.11, p ¼ 0.005) and stent area/lumen area (1.07 AE 0.24 vs. 1.27 AE 0.25, p ¼ 0.006) ratios, suggesting that mechanisms beyond vessel overstretching may contribute to dissections at proximal stent edges (Online Table 1 ). Predictors of OCT-detected stent edge dissection. Key independent predictors for OCT-detected edge dissections were the presence of atherosclerotic plaque at stent edges, angle of calcification in fibrocalcific plaques, minimum FC thickness in lipid-rich plaques, presence of TCFAs, stent and lumen eccentricity, stent-to-lumen diameter, and area ratios (Fig. 5) .
Qualitative and morphometric analysis of stent edge dissections. Overall, longitudinal dissection length measured 2.04 AE 1.60 mm, and the majority of dissections appeared as flaps (96.2%). Forty-one dissected edges (38.7%) had more than 1 flap, and in 9 (8.5%) edges, flap and cavity coexisted. In most dissections, the depth of vascular injury was beyond the intimal/atheroma layer (48.1% medial and 4.7% adventitial). Intramural hematoma was detected in 10 (9.4%) dissected edges, with 9 of them located at distal edges. Only 1 intramural hematoma (10%) was located at a nondiseased edge, and 9 (90%) were located at sites with eccentric plaque. Intraluminal thrombus was detected in 4 (3.8%) dissected edges, with equal distribution between distal and proximal edges (Table 4) . Dissections concomitantly identified by OCT and angiography (n ¼ 17) were longer, had bigger flap dimensions, and had deeper vessel injury than dissections seen only by OCT (n ¼ 89). All dissections seen by both OCT and angiography extended beyond the intimal/atheroma layer (Online Table 2 ). Management of stent edge dissections. Of all 106 dissections, 24 (22.6%) were treated with additional stents. Treated dissections were longer and had more flaps per dissection, bigger flap dimensions, and deeper degrees of vascular injury in comparison to the dissections not treated ( Table 5 ). Incidence of intramural hematoma was similar between the groups, and a trend was observed towards more intraluminal thrombus in treated dissections. Of all 24 dissections treated, 13 (54.2%) had been identified by both OCT and angiography, representing 76.5% of all 17 angiography-detected dissections. The rate of dissection treatment was not significantly different between the study's Phase I (9 of 46 [19.5%] ) and Phase-II (15 of 60 [25%], p ¼ 0.641), and no significant differences were observed regarding the morphometric parameters of dissections between the 2 study phases (Table 5) . Factors identified by the multilevel univariate logistic regression analysis that predicted the decision to treat an OCT-detected dissection were the concomitant identification of dissection by angiography, dissection longitudinal length, and specific morphometric parameters by OCT ( Chamié et al.
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A U G U S T 2 0 1 3 : 8 0 0 -1 3 ( Of note, all events occurred more than 30 days after the index procedure, and happened in patients in whom the dissections were only seen by OCT, as the majority of dissections concomitantly seen by OCT and angiography were treated. Edge dissections in patients with and without MACE had similar morphometric characteristics (Online Tables 3 and 4 ). In the group of patients without dissection, there were 5 deaths (4 of cardiac origin) and 2 nonfatal MIs, from which 1 was due to severe in-stent restenosis and required revascularization. There were no stent thrombosis in the edge dissection group and only 1 probable stent thrombosis in a patient without dissection who had a cardiac death in the first week after the index procedure (Table 7) .
Discussion
We report the first large comprehensive OCT evaluation of arterial wall injury at stent edges in the daily clinical practice. The present study led to the following observations: 1) edge dissections after stenting are frequently detected by OCT, with a "true" incidence of 33.9% when OCT was performed in all treated vessels (Phase I) or a "real-world" rate of 40.9% when OCT was selectively used per the operator's discretion (Phase II); 2) most OCT-detected edge dissections (84%) were not apparent on angiography; 3) atherosclerotic disease was frequent (95.3%) at dissected edges, with the odds of having a dissection increasing by more than 6 times in the presence of a plaque; 4) circumferential calcium angle, FC thickness over lipid-rich plaques, and vessel overstretching by the stent were independent predictors for the occurrence of edge dissections; 5) a relatively high frequency (22.6%) of OCT-detected dissections were treated with additional stenting, which was driven by the concomitant presence of dissection on angiography in addition to OCT findings; and 6) patients with untreated OCT-detected edge dissections had similar 12-month outcomes compared with patients without dissection. Incidence of stent edge dissection. Edge dissections poststenting have been observed in 5% to 23% of cases examined by IVUS (3, 30) . A recent OCT investigation reported the presence of stent edge dissections in 25% of 73 patients (14) . During the first phase of the present study, edge dissections were detected in 33.9% of 116 treated lesions examined by OCT. Although these figures may represent the "true" incidence of OCT-detected stent edge dissection, the expected incidence of dissections in everyday practice may be relatively higher (40.9%), likely because of more selective use of OCT. Our findings further confirm that dissections are twice more likely to occur in distal edges in comparison to proximal edges (67.9% vs. 32.1%) (7, 14) . Predictors for stent edge dissection. Incomplete lesion coverage has been associated with increased risk of procedural complications and poor clinical outcomes (31, 32) . The somewhat expected, yet alarming, high prevalence of "untreated disease" found at stent margins is in part related to PCI technique and limitations of angiography to properly determine disease severity and extension. Only 4.7% of all dissected edges were free of disease by OCT, contrasting to 24.6% of the nondissected edges (p < 0.001). The odds of having an edge dissection were 6 times higher when the stent was placed over a diseased region than over a normal vessel (OR: 6.15, 95% confidence interval: 2.09 to 18.11, p ¼ 0.001). These results are in line with previous IVUS observations (30, 33) and underscores a modifiable factor, that is, judicious PCI technique to minimize longitudinal geographic miss, that may further improve PCI results.
Beyond the presence of disease at stent edges, the type of plaque may also play an important role in the pathogenesis of edge dissections. Previous work utilizing IVUS to understand angiographic haziness at stent edges demonstrated a significantly higher prevalence of echolucent "soft" plaques in patients with peristent injury than in controls (20) . In the current study, the majority of plaques were fibrotic or fibrocalcific in both dissected and nondissected edges, and OCT-defined lipid-rich plaques represented only 23.8% of plaques at dissected edges. Differences between OCT and IVUS properties to detect lipid may explain these somewhat discordant results on the association of lipid-rich plaques and stent dissection. Our study, however, expands upon these prior observations and shows that morphometric aspects of FC overlying lipid/necrotic core pose significant risk for edge dissections. The incidence of TCFA was higher in dissected edges than in nondissected edges, and minimum FC thickness over lipid-rich plaques was significantly smaller. Furthermore, FC thickness was identified as an independent predictor for the occurrence of edge dissections. Based on an exploratory receiver-operating characteristic curve analysis, a minimum FC thickness 80 mm was the best cutoff to predict stent edge dissection on a lipid-rich Values are mean AE SD or n (%). p value is for comparison between OCT-detected dissection at the distal and proximal edges.
OCT ¼ optical coherence tomography.
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A U G U S T 2 0 1 3 : 8 0 0 -1 3 plaque, with a sensitivity and specificity of 73.9% and 72.5%, respectively. Presence of calcification has been traditionally identified as an independent predictor of coronary dissection after either balloon angioplasty or stent implantation (7, 34, 35) . Gonzalo et al. (14) assessed 24 stent edge dissections with OCT and found fibrocalcific plaques (43.8%) to be more frequent at distal dissected edges than were fibrotic plaques (10%, p ¼ 0.009). In the current study, we found a similar frequency of fibrocalcific plaques in dissected edges (40.6%), but that was not significantly different from nondissected edges (30.7%, p ¼ 0.137). Notwithstanding, the circumferential extension, but not the simple presence of calcification, was identified as an independent predictor of stent edge dissection (OR: 1.02 for every 1 increase; 95% CI: 1.00 to 1.03, p ¼ 0.017). OCT enabled assessment of calcium depth, but this was not associated with occurrence Values are mean AE SD or n (%).
OCT ¼ optical coherence tomography. of dissection. An exploratory receiver-operating characteristic curve analysis revealed an angle of calcification !72 to be the best cutoff to predict calcium-related edge dissections, with a sensitivity of 71.1% and specificity of 71.2%. These results suggest that loss of circumferential vessel compliance might be more important in the pathogenesis of calciumrelated dissections rather than the presence or depth of calcification.
Mechanical factors, such as vessel overstretching by an oversized stent relative to the reference vascular dimensions, have also been suggested as an important cause of dissection at stent edges. In the present study, we found significantly greater stent/artery ratios in dissected edges than in nondissected edges. For every 1% increase in stent diameter/ lumen diameter or stent area/lumen area ratios, the odds of having a dissection increased 22% and 12%, respectively. As anticipated, vessel overstretching was more pronounced in the distal compared with the proximal dissected edges. Of note, the mean stent/lumen diameter and area ratios of 1.04 and 1.07 indicate an adequate stent sizing at proximal edges, suggesting that other factors such as plaque type, FC thickness, and circumferential calcification play a more significant role in proximal edge dissections.
OCT assessment of stent edge dissections and management.
Of all 106 dissections, 24 (22.6%) were treated with additional stents. As expected, treated dissections were longer, more complex, and deeper in comparison to the dissections left untreated. The presence of intramural hematoma did not impact the decision to treat; only 3 of the 10 dissections with intramural hematoma were treated. Operators were more prone to treat dissections observed on both OCT and angiography. Importantly, the time period of the study was not identified as a predictor for the decision to treat, indicating that the learning curve of interpreting OCT images did not influence the decision to further intervene upon dissected stent edges. Clinical implications. The arterial wall usually responds to mechanical injury through a series of cellular and molecular mechanisms implicated in neointimal hyperplasia formation and vessel remodeling, which ultimately may lead to restenosis (36) . In addition, plaque disruption with exposure of its prothrombotic milieu may promote acute/subacute thrombosis (6, 7) . In fact, stent edge dissections have been associated with increased short-and mid-term incidence of MACE and stent thrombosis (4) (5) (6) (7) 37) . In the present study, the 12-month MACE rate was relatively low in patients with and without edge dissections detected by OCT. Furthermore, OCT morphometric characteristics of untreated dissections in patients who developed MACE were not significantly different than dissections in patients who had uneventful outcomes. Virtually all dissections presented with TIMI flow grade 3 at the end of the procedure and were classified as National Heart, Lung, and Blood Institute type B or less. These observations suggest that angiographically "silent" dissections seen only by OCT have minimal impact on outcomes after stent deployment in modern PCI. However, these findings should be interpreted with caution. The more severe OCT-detected dissections were treated. As a result, edge dissections left untreated were smaller in size, had shorter longitudinal extension, and were usually more superficial, with their depths limited to the intimal/atheroma layer (Table 6 ). Nevertheless, the present results are reassuring in that minor, non-flow-limiting OCT-detected dissections have a benign course and are not associated with an increased incidence of adverse outcomes (34, (38) (39) (40) (41) . Study limitations. The present study is insufficient to support specific criteria to guide clinical decision making on which OCT-detected dissection should be treated, but it indicates that dissections with longitudinal length 1.75 mm, with <2 concomitant flaps, flap depth 0.52 mm, flap opening 0.33 mm, and not extending deeper than the media layer have favorable outcomes and can be left untreated. Future studies would be required to understand whether the more complex characteristics of the treated dissections in the present study would be associated with poor outcomes if left untreated. However, such study will be difficult to be conducted due to the inherently ethical limitations of leaving potentially lifethreatening vascular complications untreated. Another potential limitation is that the absence of serial OCT examination precludes conclusions on the mechanisms of stent edge dissection healing and determination of predictors for dissection persistence over time, aspects that need to be investigated in future works.
